Observational studyCancer research and treatment2023

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer.

Xiaochen Fei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.